- Home
- OCUL vs QDEL Comparison
OCUL vs QDEL Comparison
Compare OCUL & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCUL | QDEL |
|---|---|---|
| Founded | 2006 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2014 | 2022 |
Fundamental Metrics
Financial Performance| Metric | OCUL | QDEL |
|---|---|---|
| Price | $7.63 | $14.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | $23.56 | ★ $32.75 |
| AVG Volume (30 Days) | ★ 4.8M | 1.4M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | $1,990,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $7.93 | $3.51 |
| Revenue Next Year | $94.00 | $3.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.48 | N/A |
| 52 Week Low | $6.23 | $15.08 |
| 52 Week High | $16.44 | $37.24 |
Technical Indicators
Market Signals| Indicator | OCUL | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 34.58 | 27.98 |
| Support Level | $6.23 | N/A |
| Resistance Level | $12.38 | $30.65 |
| Average True Range (ATR) | 0.41 | 1.21 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 1.20 | 4.36 |
Price Performance
Historical ComparisonAbout OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.